<DOC>
	<DOCNO>NCT02016391</DOCNO>
	<brief_summary>The purpose study evaluate effect dexmedetomidine pain radiofrequency ablation liver kidney tumour .</brief_summary>
	<brief_title>Effects Dexmedetomidine During Radiofrequency Ablation Abdominal Tumours</brief_title>
	<detailed_description>Although radiofrequency ablation ( RF ) accept best therapeutic choice patient early stage hepatocellular carcinoma liver transplantation surgical resection suitable option , still perform hospital experience far limited ( Goldberg &amp; Ahmed , 2002 ; Shiina et al. , 2005 ) . In addition , RF ablation emerge viable alternative surgery inoperable patient limited hepatic metastatic disease , especially colorectal cancer . Although radiofrequency ablation accept safe effective treatment liver kidney tumour , study address periprocedural pain . Thus , optimal anaesthetic procedure still determine . Currently institution RF perform monitored sedation procedure use remifentanil infusion supplement midazolam bolus , consider necessary . However , use remifentanil midazolam combination quite difficult avoid deep respiratory depression . Dexmedetomidine α2-adrenoreceptor agonist sedative , analgesic anxiolytic effect , selective α2-adrenergic effect clonidine . Dexmedetomidine great deal potential arena give analgesic anxiolytic property preserve respiratory drive ( Bergese SD et al. , 2010 ) . All patient receive dexmedetomidine 0.4 µg/kg/hr infusion start procedure . The infusion continue whole RF procedure . At time patient receive remifentanil infusion accord TCI ( target control infusion ) protocol . Plasma concentration target set 0.5 ng/ml , necessary , increased achieve comfortable state patient ( Ramsey Sedation Scale : 2-3 ) .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>liver or/and kidney cancer radiofrequency ablation procedure plan sign informed consent form patient refusal pregnancy know allergy dexmedetomidine remifentanil atrioventricular block grade II III significant cardiac conduction disturbance stroke low blood pressure respond treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>